adyn raises $2.5M seed round from Lux Capital, M13 and investors including 23andMe CEO to launch birth-control test

Seattle startup adyn raised a $2.5 million seed round co-led by Lux Capital and M13 to launch an at-home birth control optimization test later this year, and currently has a waitlist for early access. The test analyzes hormone levels to identify birth-control–related side effects and pairs personalized results with telemedicine and prescription delivery.

No comments yet.